Medscape Newsfeed:
- Trump Plans to Fire US FDA Chief Makary, Sources Say
The White House signed off on a plan to fire U.S. Food and Drug Administration Commissioner Marty Makary, according to sources familiar with the matter, in what could be the... Reuters Health Information
- Factor XIa Tied to Benefit Beyond Stroke Prevention
Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the recurrent ischaemic stroke risk, but when they do occur, they are less likely to be disabling or fatal. Medscape Medical News
- NICE Recommends Givinostat for Duchenne Muscular Dystrophy
NICE has recommended givinostat for all DMD types, offering around 530 patients a drug that may delay disease progression by up to 5 years. Medscape News UK
- Experts Race to Write Guidance to Contain First Ship-borne Hantavirus Outbreak
As the cruise ship hit by a hantavirus outbreak sails towards Tenerife, World Health Organization officials are racing to draw up step-by-step guidance for what should... Reuters Health Information
- Gastric Sleeve Endoscopy Continues Weight Loss after GLP-1s
Researchers link the minimally invasive procedure to significantly greater total weight loss compared to lifestyle modification alone at 1 year after stopping GLP-1 therapy. Medscape Medical News
NIH Newsfeed:
- Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings
NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs
- NIH-funded study suggests that testosterone suppresses brain tumor growth in males
Findings may warrant exploration of the hormones as glioblastoma treatment
- Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking
Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.
- Symptom-based approach treats opioid withdrawal in newborns with minimal drug exposure
NIH-funded clinical trial shows that the new approach could also decrease time in the hospital.